SNOMED CT Editorial Guide

Search

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 4 Next »

Overview

|Product containing x (medicinal product)| concepts are abstract representations of the active ingredient(s) for a medicinal product. The medicinal product must contain the active ingredient(s) specified in the FSN but may also contain a modification of the active ingredient(s) specified in the FSN or may contain additional active ingredient(s).

For example,

    • Product containing axitinib (medicinal product)
    • Product containing abacavir and lamivudine (medicinal product) 

Modeling

Stated parent concept

763158003 |Medicinal product (product)

Semantic tag(medicinal product)
Definition status900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|

Attribute:

Has active ingredient

Range: <105590001 |Substance (substance) excluding concepts representing structural groupers, dispositions, or combined substances

Cardinality: 1..* 

  • There is no technical limit on the number of Has active ingredient attributes that may be added to a concept; a practical limit may be imposed at a later date.

Naming Guidelines

FSN

Use the following pattern for the FSN; align naming and case sensitivity with the FSN for the concept that is selected as the attribute value, excluding the semantic tag.

For multiple ingredient drug products, the active ingredients must be in alphabetical order and separated by the word “and”.

  • Product containing <Active ingredient FSN> (medicinal product)
  • Product containing <Active ingredient FSN> and <Active ingredient FSN> (medicinal product)
  • Product containing <Active ingredient FSN> and <Active ingredient FSN> and <Active ingredient FSN tag> (medicinal product)

For example,

      • Product containing axitinib (medicinal product)
      • Product containing abacavir and lamivudine (medicinal product)
      • Product containing abacavir and lamivudine and zidovudine (medicinal product)

Preferred Term

Use the following pattern for the PT; align naming and case sensitivity with the PT for the concept that is selected as the attribute value.

For multiple ingredient drug products, the active ingredients must be in alphabetical order and separated by the word “and”.

  • <Active ingredient PT>-containing product
  • <Active ingredient PT>- and <Active ingredient PT>-containing product
  • <Active ingredient PT>- and <Active ingredient PT>- and <Active ingredient PT>-containing product

For example,

      • Axitinib-containing product
      • Abacavir- and lamivudine-containing product
      • Abacavir- and lamivudine- and zidovudine-containing product
Synonym

Synonyms matching the FSN are not required.

Exemplars

The following illustrates the stated view for 714627007 |Product containing aflibercept (medicinal product)|:

The following illustrates the inferred view for 714627007 |Product containing aflibercept (medicinal product)|:

The following illustrates the stated view for 412556009 |Product containing codeine and paracetamol (medicinal product)|:

The following illustrates the inferred view for 412556009 |Product containing codeine and paracetamol (medicinal product)|:


Feedback
  • No labels